Smoking-cessation products could save lives, reduce health costs and increase productivity, generating a 26% return on investment for every dollar that states spend on the treatments, Pennsylvania State University researchers reported in a Pfizer-funded study. The U.S. loses more than $300 billion each year on account of medical expenditures for smoking-related illnesses and premature deaths, as well as losses in workplace productivity, a representative of the American Lung Association said.

Full Story:

Related Summaries